{"title": "Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.", "author": "Greenhawt; Matthew; Shaker; Marcus; Golden; David B K; Abrams; Elissa M; Blumenthal; Kimberly G; Wolfson; Anna R; Stone; Cosby A; Krantz; Chu; Derek K; Dwamena; Ben A", "url": null, "hostname": null, "description": null, "sitename": "Allergy", "date": "2021-10-04", "cleaned_text": "Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis. Allergy ; 2022 Nov [polysorbate 80][PS]) has been recommended, but has unknown accuracy. To assess [vaccine]/ [excipient]ST accuracy in predicting all-severity [WHO]global [coronavirus]database (inception-Oct [vaccine]/ [excipient]ST The of the evidence, and QUADAS-2 assessed [risk]of [bias]. Among 20 studies of [mRNA]COVID-19 first [dose] [vaccine]reactions, 317 individuals underwent 578 ST to any one or combination of [vaccine], PEG, or PS, and were re-vaccinated with the same [vaccine]. Test (95%CrI 0.91-1). Combined for use of any of the 3 testing agents, [sensitivity]was 0.03 (95%CrI 0.00-0.08) and [specificity]was 0.98 (95%CrI 0.95-1.00). Certainty evidence moderate. ST has low [sensitivity]but high [specificity]in predicting all-severity repeat immediate "}